Vimarsana
Biggest News Aggregation in the World

Page 36 - Robert Barrow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robert Barrow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robert Barrow Today - Breaking & Trending Today

FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety Disorder - Vimarsana News

FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety Disorder

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a clinical-stage biopharmaceutical company developing...

FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety Disorder - Vimarsana News

FDA Clears MindMed IND for MM-120 in Treatment of Generalized Anxiety Disorder

NEW YORK, Jan. 25, 2022 /PRNewswire/ -- Mind Medicine Inc. , , a clinical-stage biopharmaceutical company developing psychedelic-inspired therapies for the treatment of brain-based... | January 25, 2022

Microsmallcap.com: Psilocybin and MDMA Get the Green Light for Medical Use in Canada - Vimarsana News

Microsmallcap.com: Psilocybin and MDMA Get the Green Light for Medical Use in Canada

FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Jan. 19, 2022 /PRNewswire/ -- After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received

Psilocybin and MDMA Get the Green Light for Medical Use in Canada - Vimarsana News

Psilocybin and MDMA Get the Green Light for Medical Use in Canada

/PRNewswire/ -- After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical...

MindMed Successfully Completes Phase 1 Trial Of 18-MC - Vimarsana News

MindMed Successfully Completes Phase 1 Trial Of 18-MC

This article was originally published on Microdose and appears here with permission. MindMed ended its 2021 news cycle on a somewhat mehhh&n...